Skip to main content

New Alzheimer's drug slightly slows cognitive decline. Experts say it's not a silver bullet.

Experts weigh in on whether the newly approved Alzheimer's treatment lecanemab is worth taking.

from Livescience https://ift.tt/YTJuM5a

Comments

Popular posts from this blog

Senior trip to Dominican Republic descends into disaster after group falls ill - New York Post

Senior trip to Dominican Republic descends into disaster after group falls ill    New York Post The recent Deer Creek High School graduates flew on June 8 to the embattled Hard Rock Hotel & Casino in Punta Cana, where at least two Americans have ... View full coverage on Google News from Top stories - Google News https://nyp.st/2KnWYW5